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ABSTRACT 
TRANSCRIPTION REGULATION OF THE Saccharomyces cerevisiae PHO5 GENE 
BY THE Ino2p and Ino4p BASIC HELIX-LOOP-HELIX PROTEINS 
 
FEBRUARY 2016 
YING HE, B.Sc., SICHUAN UNIVERSITY, SICHUAN, CHINA 
Ph.D.,UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor John M. Lopes 
 
The Saccharomyces cerevisiae PHO5 gene product accounts for a majority of the acid 
phosphatase activity.  Its expression is induced by the basic helix-loop-helix (bHLH) 
protein, Pho4p, in response to phosphate depletion.  Pho4p binds predominantly to two 
UAS elements (UASp1 at -356 and UASp2 at -247) in the PHO5 promoter.  Previous 
studies from our lab have shown cross-regulation of different biological processes by 
bHLH proteins.  This study tested the ability of all yeast bHLH proteins to regulate 
PHO5 expression and identified inositol-mediated regulation via the Ino2p/Ino4p bHLH 
proteins.  Ino2p/Ino4p are known regulators of the phospholipid biosynthetic genes.  
Genetic epistasis experiments showed that regulation of PHO5 by inositol required a 
third UAS site (UASp3 at -194).  ChIP assays showed that Ino2p:Ino4p bind the PHO5 
promoter.  These results demonstrate that phospholipid biosynthesis is coordinated with 
phosphate utilization via the bHLH proteins.  
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CHAPTER 1 
INTRODUCTION 
1.1 Significance of this Study  
The yeast basic helix loop helix (bHLH) family of transcription factors regulates 
several different biological processes including phosphate utilization and phospholipid 
biosynthesis.  Phosphate is an important nutrient required for cell growth and 
proliferation [1, 2].  When phosphate is limiting, Saccharomyces cerevisiae responds by 
inducing expression of genes to acquire inorganic phosphate from multiple sources.  
These genes include phosphate transporters and nonspecific scavenger phosphatases [3-5]. 
Pho5p is a central player in yeast phosphate assimilation because it accounts for more 
than 90% of the acid phosphatase activity [6].  Induction of PHO5 in response to 
phosphate depletion requires the Pho4p activator, a bHLH protein [7].  Pho4p-mediated 
regulation of PHO5 expression has been extensively investigated by many groups over 
several decades and serves as a model for eukaryotic transcription control.  Previous 
studies from our lab have shown cross-regulation of different biological processes by 
different bHLH proteins.  This study examined the ability of all nine known yeast bHLH 
proteins to regulate PHO5 expression and identified inositol-mediated regulation via the 
Ino2p/Ino4p bHLH proteins [1, 2].  Ino2p and Ino4p are known regulators of 
phospholipid biosynthetic genes.  Genetic epistasis experiments showed that regulation of 
PHO5 by inositol required a third UAS site (UASp3 at -194) and ChIP assays showed 
that Ino2p:Ino4p bind the PHO5 promoter at this same location. These results 
demonstrate that phospholipid biosynthesis is coordinated with phosphate utilization via 
the bHLH proteins.  
2 
1.2 Basic Helix-Loop-Helix Proteins in Eukaryotes  
 
1.2.1 General Properties of Basic Helix-Loop-Helix Proteins 
Basic helix-loop-helix (bHLH) proteins comprise a group of extensively studied and 
functionally important eukaryotic transcriptional regulators.  Typical bHLH proteins are 
composed of two domains: the basic-charged domain, which binds to DNA, and the 
amphipathic helix-loop-helix domain, which enables the interaction between HLH 
monomers (Fig. 1) [8].  Generally, bHLH proteins regulate transcription through direct 
binding to regulatory regions of genes. 
There are several unique features that make the bHLH protein family particularly 
suited for combinatorial control of gene expression. First, its structure allows for the 
formation of homodimers or heterodimers with several different partners. For example, 
the S. cerevisiae Ino4p bHLH protein is a protein interaction hub that interacts with all 
yeast bHLH proteins [9].  Second, the basic regions of two monomers have relatively 
limited DNA-binding specificity, since most interact with a conserved core sequence 
known as the E box: ’5-CANNTG-3’ (Fig. 1) where the two central nucleotides dictate 
specificity [10].  In some cases, the E-box flanking sequences aid in recognition by 
specific bHLH proteins [11]. Third, some bHLH proteins, such as Ino2p, autoregulate 
their own expression [12].  Fourth, some family members lack the basic charged DNA 
binding domain and therefore can dimerize with other bHLH proteins but prevent their 
binding to DNA. For example, the Id HLH protein acts as a dominant inhibitor by 
heterodimerizing with other bHLH proteins, E12 and E47 [13, 14].  Lastly, some bHLH 
proteins are regulated by intracellular compartmentation. Some examples are Pho4p, 
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Rtg1p, and Rtg3p, which translocate to the nucleus under activating conditions and are 
present in the cytoplasm under repressing conditions [15-17].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 
Fig.1.  Structure of the Pho4p-DNA complex [8].  Ribbons represent helical regions; thin 
tubes for irregular secondary structures.  
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1.2.2 Phylogenetics and Nomenclature of bHLH Protein Families in 
Eukaryotic Organisms 
Since the discovery of the bHLH family and its DNA binding and dimerization 
capability a decade ago [18], increasing numbers of bHLH proteins have been identified 
in eukaryotic organisms including yeast, Arabidopsis, C. elegans, Drosophila, mouse, rat 
and human [19-21].  In 1989, the initial classification of bHLH protein family was based 
on ubiquitous (Class A) and tissue-specific (Class B) expression [18].  In 1997, the first 
large-scale phylogenetic analysis provided an expanded evolutionary classification of 242 
bHLH motif-containing proteins [21].  This classification was performed using only the 
bHLH motif because the flanking regions for proteins from independent clades are very 
divergent.  Based on E-box-binding specificity and the amino-acid patterns, they were 
arranged into four groups [21].  Class A proteins bind to CAGCTG and have a distinctive 
pattern of amino acids at sites 5, 8, and 13 of the basic region.  Class B bind to CACGTG 
and have a basic amino acid (either K or H) at site 5 and arginine at site 13.  Class C 
represents a separate lineage derived from Class B but has no consistent amino acid 
configuration at site 5, 8, or 13.  Class D proteins lack the basic DNA binding region, 
have a very low frequency of basic residues in the first 13 amino acid sites, and 
frequently have prolines at sites 4 and 9.  However, this classification has some 
limitations in considering protein function.  For example, Class A includes several tissue-
specific bHLH proteins and some functionally unrelated proteins.  Class B is composed 
of some functionally divergent proteins involved in various cellular and developmental 
processes. For example, MyoD and myogenin participate in muscle cell differentiation 
[22] while the Ngn (Neurogenin) family functions in neuronal development [23].  Class C 
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proteins all contain the PAS domain, which is named for the first three proteins identified 
with this motif: the Drosophila Period (Per), human Arnt, and Drosophila Single-minded 
(Sim) [24].  Class D includes inhibitors of differentiation (Id), which lack a basic domain 
and are thus unable to bind DNA.  In mammals there are four different Ids: Id1, Id2 and 
Id3 are ubiquitously expressed; while Id4 is primarily expressed in brain, kidney and 
testis [25, 26]. 
In 2008, a further phylogenetic analysis of seven different species (human, mouse, rat, 
worm, fly, yeast, and plant) was performed on 541 bHLH-encoding genes that were 
identified using expressed sequence tags (EST) [27].  Different from the previous study, 
this study was not limited to the bHLH region, but used the entire coding region of the 
proteins.  This allowed the inclusion of other domains associated with many of these 
proteins including: zip, Orange, and PAS domains [27].  These other domains play 
known roles in protein interactions (e.g., zip for heterodimerization or homodimerization; 
PAS for ligand binding) and may function in transcriptional repression (e.g., Orange 
competes with bHLH activators [28-30]).  This study revealed a structural categorization 
involving six clades [27].  Clade 1 included only mammalian genes. Clades 2-5 contained 
genes from a mixture of species.  Clade 6 included the Arabidopsis bHLH genes only 
[27].  As expected, the majority of bHLH proteins with similar domains clustered 
together in the different clades [27]. This suggests the gene groupings are appropriately 
related to structure and potentially similar in function.  For those uncharacterized bHLH 
proteins, the position on the super phylogenetic tree in relation to known bHLH proteins 
allows for predictions of their potential functions [27].  Since these first publications, 
further studies by the Skinner lab were performed in 2010 [20].  A super-tree involving 
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six clades and all structural relationships has been established and is now available for 
four species (C. elegans, Drosophila, mouse, human) [20].  Below, I will summarize 
some of the current understanding of these bHLH proteins in various model systems. 
 
1.2.3 Caenorhabditis elegans bHLH Proteins 
C. elegans has 42 bHLH proteins [31] that are involved in very divergent biological 
process such that their loss results in phenotypes ranging from neuronal defects to 
embryonic lethality [32-34].  For example, the HLH-1 protein, a MyoD homologue, is 
essential for proper muscle function and complete morphogenesis [35].   
The HLH-2 protein in C. elegans is the sole ortholog of the Daughterless protein in 
Drosophila and because it is broadly expressed and is involved in many different cellular 
processes, the specificity of its transcriptional targets is often determined by its tissue-
specific dimerization partners.  For example, HLH-3 which belongs to the Achaete-Scute 
family, forms a heterodimer with HLH-2 and activates egl-1 to induce programmed cell 
death of the sister cells of pharyngeal neuro-secretory motor (NSM) neurons [36].  HLH-
2 also specifies mesodermal fate when combined with a Twist ortholog, HLH-8 [37].  It 
also promotes morphogenesis of sensory rays in males with LIN-32, a member of the 
Atonal family [34].  It also specifies the PVQ/HSN/PHB neuroblast with HLH-14, 
another member of the Achaete–Scute family [38].  Importantly, HLH-2 has been shown 
to be required for both specification and function of distal tip cells, as demonstrated by 
RNA interference (RNAi) analysis [39]. 
The HLH-6 gene encodes a bHLH transcription factor that is expressed in all five 
pharyngeal glands [40, 41].  The pharynx is a neuromuscular organ that draws in food 
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from the environment and initiates digestion.  It is composed of 80 cells representing five 
distinct cell types: muscles, marginal cells, neurons, epithelia and glands [40]. 
Though lots of intensive work has been done with individual C. elegans bHLH 
proteins, global scale studies of the architecture and functionality of the bHLH 
transcriptional networks remain unclear.  Several integrated regulatory networks have 
been reported for C. elegans genes.  The first connects genes involved in early 
embryogenesis by protein-protein interactions, phenotypes and expression profiles [42].  
The second is a probabilistic network that used various data types and that can be used to 
predict genetic interactions [43].  Unlike the first two, the third network developed in the 
Walhout lab focused on transcriptional factors or provided interactions between proteins, 
DNA sequences, and tissues or cell types [44]. Different from the common strategy of 
chromatin-immunoprecipitation followed by PCR sequencing or microarray (ChIP-Seq or 
ChIP-chip), the Walhout lab performed a gene-centered method to generate a 
transcription factor binding profile.  First they performed large-scale yeast two-hybrid 
screens to map the bHLH protein interaction networks in C. elegans [45, 46], then they 
used yeast one-hybrid screens to chart the protein–DNA interactions that control gene 
transcription [47, 48]. They comprehensively determined the dimerization, spatial and 
temporal expression and DNA binding specificities for nearly all members of the C. 
elegans bHLH family.  
 
1.2.4 Drosophila melanogaster bHLH Proteins 
It is well studied in D. melanogaster that bHLH proteins are involved in various 
development processes, including: body segmentation, sex determination, and 
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epitheliogenesis /neurogenesis [49-51].  Anteroposterior pattern formation in Drosophila 
depends on a cascade of segmentation genes.  Several bHLH transcription factors are 
regionally expressed within the embryo.  For example, the bHLH protein Hairy represses 
the expression of runt, fushi tarazu (ftz) and paired (prd), which are pair-rule 
segmentation genes of Drosophila [52-55]. 
Drosophila sex determination is primarily regulated by the ratio of X chromosomes to 
autosome haploid sets [56].  There are several genes encoding bHLH proteins including, 
daughterless (da), sisterless-b (sis-b) and hairy, involved in sex determination [56].  The 
da gene product is abundant and present in equal amounts in both male and female 
embryos [56, 57].  The gene sis-b is encoded on the X chromosome and its protein 
product can form heterodimers with the da product [58].  Because females are 2X, they 
make twice as much Sis-b as males, and thus only females make sufficient concentrations 
of Da-Sis-b heterodimers to activate sxl expression [59].  Hairy is another HLH protein 
which dimerizes with Sis-b and makes an inactive dimer thus repressing sxl expression. 
Many Drosophila bHLH proteins have been implicated in the control of neurogenesis.  
Drosophila neural or epidermal cells can develop from the same ectodermal cells [60].  
The concept of a ‘proneural’ gene was first defined in Drosophila and refers to genes that 
are responsible for the development of neuroectodermal progenitor cells [61-63].  The 
proneural genes encode bHLH proteins and are expressed in groups of cells called 
proneural clusters.  In the middle of these clusters, one progenitor cell will lead to the 
formation of different types of neurons in the central and peripheral nervous systems [64, 
65].  The remaining cells of proneural clusters will develop into epidermal cells [66].  As 
early as the 1920s, some Drosophila mutants were found to lack subsets of external sense 
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organs or bristles [67].  By the late 1970s, a complex composed of four proteins was 
identified as involved in the early steps of neural development in Drosophila [68].  The 
genes encoding the four proteins were named achaete (ac), scute (sc), lethal of scute (lsc) 
and asense (aseA) [62, 69].  Further studies showed they share sequence similarity in 
what was later defined as the bHLH domain [18, 70].  Later a proneural gene, atonal 
(ato), was isolated and shared about 45% identity in the bHLH domain, compared with 
70% identity among achaete-scute complex (asc) family members [67].  The atonal 
family includes other two genes, amos (absent MD neurons and olfactory sensilla) and 
cato (cousin of atonal) [71-73].  Beside the asc family and ato family, there are five other 
distinct families in Drosophila based on closer sequence similarities in the bHLH domain: 
E proteins, Olig family, NeuroD family, Neurogenin family, and Nscl family [67]. 
The Notch signaling pathway is another well studied, highly interconnected network 
in Drosophila which involves bHLH proteins.  The transmembrane Notch receptor 
interacts with its ligand Delta resulting in cleavage of the intracellular domain of Notch 
(NIC), which then translocates to the nucleus and acts as a coactivator for the protein, 
Suppressor of Hairless (Su(H)) [74-77]. Then the Su(H)/NIC complex activates 
expression of target  genes including the repressor genes of Enhancer of split complex 
(E(spl)-C)[74, 75, 78], which encodes seven bHLH proteins (m3, m5, m7, m8, mA, mB, 
and mC) [79, 80].  All of these proteins have been conserved structurally and functionally 
during eukaryotic evolution, and are considered core components of the Notch pathway 
[81].  
 
1.2.5 Arabidopsis thaliana bHLH proteins 
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Arabidopsis has the largest number of bHLH proteins (162) among all eukaryotes 
studied to date [82-84] (compared with 128 in mouse [85] and 118 in human [20]).  In a 
genome-wide study, the Weisshaar group divided 133 of these bHLH genes into 12 
subfamilies based on structural similarities such as the number of introns within 
conserved positions, the predicted lengths for the encoded proteins, and positions of the 
bHLH domain [84].  It is not surprising that Arabidopsis bHLH members are involved in 
a broad range of growth and developmental signaling pathways, including light signaling 
[86-94], brassinosteroid and abscisic acid signaling [95-99], gynoecium development 
[100], abiotic stress responses [101], flavonoid biosynthesis [102, 103], axillary meristem 
formation [104, 105], flowering time control [106], trichome and root hair differentiation 
[107-110], and stomatal patterning [111-114]. 
Light is a key environmental factor that regulates plant growth and development. 
Plants detect light through an array of photoreceptors, each responding to specific regions 
of the light spectrum.  For example, the phytochrome (phy) family perceives and 
responds to the red and far-red regions [88].  The phy family in Arabidopsis is composed 
of five members (phyA, phyB, phyC, phyD, and phyE) [88].  They interact with a small 
subset of bHLH transcription factors called PIFs (phytochrome-interacting factors), 
which belong to the fifteen-member Subfamily VII of the Arabidopsis bHLH family [84, 
87, 88, 115].  The PIFs have been found to bind in a sequence-specific manner to a core 
DNA G-box motif (5’CACGTG3’) [89].  The current model for PIF function in light 
signaling pathways is as follows [88].  In the dark, PIFs are constitutively localized to the 
nucleus, whereas Phys are localized to the cytosol.  PIFs bind to the G-box of the 
promoter region and activate the expression of downstream genes.  Induced by the signal 
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of light, Phys convert to the active Pfr forms and migrate into the nucleus [116, 117] and 
interact with PIFs, which results in phosphorylation of PIF3 and possibly other PIFs 
either directly or indirectly [93, 118].  The phosphorylated forms of PIFs are recognized 
by an ubiquitin ligase and are subsequently degraded by the 26S proteasome [119].  The 
light-induced proteolytic removal of PIFs results in repression of the downstream genes 
[120]. 
In Arabidopsis, the first reported bHLH transcription factors were GL3 and EGL3, 
which play important roles in root hair and leaf hair (trichome) control [108, 121, 122]. 
These bHLH proteins serve as linkers between the R2R3-MYB transcription factors 
(including GL1, for trichome differentiation; WER, for root hair cell fate control) and the 
WD40 repeat protein TTG1.  The three proteins form a linear activation complex [108, 
110, 121, 123-125].  The active transcription complex, R2R3-MYB-bHLH-TTG1 
positively regulates the downstream gene GL2 to promote non-hair cell and trichome 
differentiation [108, 124, 126, 127].  In contrast to R2R3-MYB factors, six R3-MYB 
factors (including CPC, TRY, TCL1, ETC1, ETC2, and ETC3) possess only the DNA-
binding domain without an activation domain [128-131].  R3-MYB factors are activated 
by the trimeric activation complex, migrate to neighboring cells, and integrate 
competitively with R2R3-MYB into the trimeric complex, rendering it inactive [125, 129, 
130, 132-134].  MYC1, another bHLH gene belonging to the same subfamily (IIIf) as 
GL3 and EGL3, functions upstream of GL2, through the interactions with MYB proteins 
and TTG1 [109, 135].  Unlike Gl3p and Egl3p, which function as homodimers or 
heterodimers, Myc1p tends to work as a monomer and is expressed mainly in root hair 
cells [108, 109, 123, 136].  Similar to GL3/EGL3, MYC1 is negatively regulated by WER 
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and positively regulated by CPC [124, 136].  A recent genome-wide analysis 
demonstrated more bHLH genes that participate in root epidermal cell development, 
including bHLH54, bHLH66, and bHLH82 (subfamilies VIIIc and XI) [136]. 
Stomata are microscopic pores found in land plants and play critical roles in gas and 
water vapor exchange with the atmosphere [113].  Stomata formation occurs in four 
stages: meristemoid mother cell (MMC), meristemoid, guard mother cell (GMC), and 
guard cells [113, 114].  Three closely related bHLH genes, SPEECHLESS (SPCH), 
MUTE, and FAMA, function consecutively as positive regulators of stomata formation, 
which involved respectively the transition from MMCs to meristemoids to GMCs to 
guard cells [112, 113, 137-139]. 
 
1.2.6 Mammalian bHLH Proteins (Mouse and Human) 
There are a large number of bHLH genes in mammals (128 in mouse [85] and 118 in 
human [20]) which regulate neurogenesis, myogenesis and hematopoiesis [140-143].  E-
proteins are an important family that belongs to the bHLH proteins and include E2A, E2-
2 and a HeLa E-box binding protein (HEB) [144, 145].  These genes are expressed in a 
broad array of tissues, including but not limited to, hematopoietic, muscle and nervous 
tissue [145-147].  E-proteins can regulate gene expression in a tissue-specific manner by 
forming functional heterodimers with tissue-specific bHLH proteins.  One example is the 
regulation of myogenesis by E2A and the muscle-specific bHLH protein MyoD [146].  
Lymphocyte B-cell development is also dependent on E-protein homodimers, particularly 
E2A homodimers [148]. 
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Mammalian neural progenitor cells (NPCs) are responsible for generating the diverse 
types of neurons and glial cells that build the nervous system [149].  It has been shown 
that bHLH factors play key roles in self-renewal of NPCs and fate determination of 
neurons, oligodendrocytes, and astrocytes [67, 150, 151].  Repressor bHLH factors like 
Hes1 regulate the self-renewal of NPCs [152-154].  Hes factors inhibit neurogenesis via 
two independent mechanisms: direct transcriptional repression by binding to promoters of 
target gene such as Ascl1 and Neurog2 [155, 156] and by forming a complex with a 
proneural bHLH protein to repress target gene expression [157].  Proneural bHLH 
transcription activators such as Ascl1 and Neurog (Ngn) family induce neuronal 
differentiation [67].  Mouse and human have 3 Ngn paralogs: Ngn1, Ngn2 and Ngn3 
[158].  In contrast to the roles of Ngn1 and Ngn2 in neurogenesis, Ngn3 participates in 
gliogenesis to specify differentiation of both astrocytes and oligodendrocytes [159].  
They bind to target DNA sequences as heterodimer complexes with ubiquitously 
expressed bHLH E proteins (E12, E47, HEB, or E2-2) [67, 160, 161].  They up-regulate 
the expression level of Notch signaling ligands, such as the transmembrane proteins 
Delta-like1 (Dll1) and Jagged1 (Jag1) [140, 162, 163].  Olig1 and Olig2 are also bHLH 
proteins which regulate oligodendrocyte differentiation, while Hes1 induces astrocyte 
formation at later stages [150, 164-166]. 
The myogenic regulatory factors (MRFs) form a group of bHLH transcription factors 
(MyoD, Myf5, myogenin, and MRF4) that regulate mouse skeletal muscle development 
[167].  MRF proteins dimerize with other HLH-containing proteins such as E12, E47, 
HEB, and ITF2 and these heterodimers bind to consensus E-boxes of target genes in 
skeletal muscles [146, 168].  Myf5 and MyoD are expressed in proliferating myoblasts 
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and are subject to distinct cell cycle regulation [169].  Gene targeting and expression 
analysis have suggested the functional classification of the MRFs into two groups: Myf5 
and MyoD act as determination factors while myogenin and MRF4 act as differentiation 
factors [170].  There is a group of MEF2 encoded factors that together with MRFs also 
play important roles in myogenesis.  They produce four alternatively spliced Mef2 gene 
products: Mef2A, Mef2B, and Mef2D are ubiquitous, whereas Mef2C is restricted to 
muscle, brain, and spleen [170, 171].  Mef2 proteins and MRFs synergistically coactivate 
E-box and Mef2-site containing promoters in two steps [171-174]: they associate via their 
DNA-binding domains; and their transcriptional activation domains contact the basal 
machinery to establish an active transcriptional complex.  In addition to activating the 
expression of downstream muscle genes, MEF2 factors also regulate the expression of 
myogenin, MyoD and MRF4 genes [171, 175-177]. 
In mammals, the bHLH proteins Myc/Mad/Max form a heterodimer network which 
plays important roles in cell proliferation, differentiation, death, and cancers such as 
human Burkitt’s lymphoma, breast cancer, and colon cancer [178-181].  A number of 
genome-wide studies of heterodimer target genes and binding sites suggest that this 
network controls between 10% and 15% of all mammalian genes [182].  Working as a 
hub in the network, Max forms heterodimers with members of the Myc and Mad protein 
families [181].  Myc proteins include c-Myc, N-Myc, and L-Myc [181].  Mad proteins 
include Mad1, Mxi1, Mad3, and Mad4 [183-185].  The recent model is that the different 
heterodimers of the Myc/Mad/Max function as a transcriptional on-off switch via histone 
acetylation modifiers [186].  The ‘on’ position of the switch is composed of Myc/Max 
heterodimers with associated histone acetyl transferases (HATs), whereas the ‘off’ 
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position of the switch is defined by Mad/Max heterodimers and a repressor complex 
possessing histone deacetylase activity [187, 188].  
  Inhibitor of DNA binding (Id) proteins, including Id1, Id2, Id3 and Id4, are a 
subfamily of helix-loop-helix transcription factors [189]. The mouse Id1 gene identified 
in 1990 was the first cloned Id gene [190]. These proteins lack the basic DNA binding 
domains, therefore they function entirely by dimerization with other transcriptional 
regulators, mainly bHLH factors. The heterodimers of Id/bHLH fail to bind to DNA, and 
hence Id proteins function as dominant negative regulators of bHLH proteins [189, 190]. 
For example, Id1 regulates the transcription of the cell cycle inhibitor p16 by directly 
binding to its transcriptional activators E47 and Ets2 [191]. Some of the well-known 
targets of Id proteins include E proteins, Rb, p107, p130, PAX, Ets, MyoD and Myf-5 
[192-194]. The Id proteins play important roles in cell cycle control, cellular 
differentiation, hematopoiesis, tumorigenesis and adipogenesis [189, 192-194]. 
 
1.3 Saccharomyces cerevisiae bHLH Proteins  
1.3.1 Summary of S. cerevisiae bHLH Proteins 
There are nine S. cerevisiae bHLH proteins that regulate several important metabolic 
pathways, including phospholipid biosynthesis, phosphate utilization and glycolysis [9, 
195] (Fig.2).  Several of these have been extensively studied.  The first identified yeast 
bHLH protein, Pho4p, forms a homodimer required for the induction of phosphate 
utilization genes when phosphate levels are low [1, 7, 8].  The Ino2p:Ino4p heterodimer 
induces phospholipid biosynthetic gene expression in response to inositol deprivation 
[196, 197].  The Rtg1p:Rtg3p heterodimer functions to activate nuclear genes (e.g. CIT2) 
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in response to mitochondrial dysfunction [198, 199]. This response is referred to as 
retrograde regulation [200].  The Sgc1p homodimer activates expression of glycolytic 
genes (for example, ENO1) [201, 202] and is also required for Ty1-mediated gene 
expression [203].  Cbf1p binds to several MET gene promoters to regulate their 
transcription [204, 205] and also functions in chromosome segregation [206, 207] and 
DNA repair [204].  The two least-studied yeast bHLH proteins are Hms1p, which 
functions in pseudohyphal growth [208] andYgr290wp.  Ygr290wp lacks a basic-charged 
DNA binding region. While it is classified as a dubious ORF, a recent study revealed that 
ENO1 expression is altered in a Ygr290w deletion mutant [209].  
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Fig.2. Yeast bHLH proteins and the processes they regulate [209].  
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1.3.2 Transcriptional Regulation of PHO Genes by Phosphate 
Inorganic phosphate is an important nutrient required for the synthesis of many 
cellular components such as nucleic acids and phospholipids.  When phosphate is 
limiting in the environment, the yeast cell induces a response to acquire inorganic 
phosphate from multiple sources.  Pho4p is a transcriptional activator involving in the 
phosphate responsive signaling pathway (PHO) [210].  It was identified as the first bHLH 
protein in yeast [7, 8] and binds to several specific cis-acting sites on the target PHO 
genes: PHO5, PHO8, PHO81, PHO84 [2]. 
PHO5 gene expression is regulated by Pho4p and it was the first gene at which 
chromatin disassembly was observed.  Pho4p acts through two essential binding sites 
corresponding to the regulatory elements UAS1 and UAS2 [211].  The two sites share the 
same binding motif as c-Myc which contains the core bHLH binding site, 5’-CACGTG-
3’ [212].  The current model for this activation of PHO5 is as follows [213-215] (Figs. 3 
and 4).  Under repressing conditions (high phosphate), four nucleosomes are positioned 
such that two cover the UAS2 element and the TATA box.  Upon activating conditions 
(low phosphate), these nucleosomes are disassembled.  Under repressing conditions, the 
Pho2p activator binds to UAS1 (nucleosome-free region) and recruits the NuA4 complex 
(Nucleosome Acetyltransferase of histone H4).  NuA4 acetylates histones H4 and H2A 
which pre-disposes the chromatin for binding Pho4p.  However, under repressing 
conditions there is only basal expression of PHO5 because Pho4p is hyperphosphorylated 
by the cyclin-dependent kinase (CDK) complex Pho80p/Pho85p and exported into the 
cytoplasm via the Msn5p receptor [216, 217].  Though some in vivo footprint data 
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suggest that Pho4p is not completely eliminated from the nucleus, it is predominantly in 
the cytoplasm as shown by immunofluorescence microscopy [15, 218]. 
Upon phosphate depletion, the Pho80p/Pho85p complex is inactivated by the CDK 
inhibitor Pho81p [219] and the hypophosphorylated Pho4p translocates to the nucleus 
and binds to UAS1 and UAS2 sites.  The Pho2p and Pho4p activators bind DNA with the 
assistance of SWI/SNF (ATPase dependent chromatin remodeling complex) and SAGA 
(HAT complex), but both of these complexes are not stably bound to the PHO5 promoter 
DNA.  Induction requires promoter nucleosome disassembly by Asf1p (nucleosome 
chaperone), which in turns allows the recruitment of the general transcriptional 
machinery (RNA PolII, TBP, TAF) and stable recruitment of SAGA and SWI/SNF. 
Regulation of the PHO system by Pho4p is obviously well studied.  The upstream and 
downstream components in this system are also understood.  For example, a microarray 
analysis of PHO regulatory mutants identified 22 target genes which fell in several 
categories: phosphatases, phosphate transporters, cycline-dependent kinases, 
phosphodiesterase, accumulation and utilization of polyphosphate [3, 220].  Yeast has at 
least six species of acid and alkaline phosphatases and inorganic phosphate transporters.  
Most of these genes are coordinately repressed by phosphate in the growth medium.   
There are 12 structural genes [2]: PHO5 encoding the major fraction of acid phosphatase, 
PHO10 (PHO12) and PHO11 encoding phosphatase isozymes, PHO8 encoding an 
alkaline phosphatase, PHO3 for a thiamine phosphatase, PHO13 for a specific p-
nitrophosphatase, PHO9 encoding a protease for Pho8p maturation, and PHO84/86/87/88 
and GTR1 which are associated with phosphate transporters. There are 8 regulatory genes 
[2]: PHO2, PHO4, PHO6, PHO7, THI3, PHO80, PHO81 and PHO85.  In addition to 
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PHO5, Pho4p has been shown to bind to a UAS sequence in the promoter regions of 
PHO8, PHO81 and PHO84 [2].  All three of these genes are induced to different levels in 
low Pi conditions [221, 222].  Except for the PHO8 promoter, all these genes required the 
binding of Pho2p [2]. 
A systematic genetic screen of a yeast deletion collection for mutants defective in 
PHO5 regulation identified the ADK1 and ADO1 genes (adenosine regulation) as 
functioning upstream of Pho81p [223, 224]. The screen also identified genes in histone 
acetyltransferase complexes, chromatin remodeling complexes, phospholipid synthesis, 
alanine transportation, glucose repression, salt stress response and global transcriptional 
repression [225].  Subsequent studies found that inositol heptakisphosphate (IP7) serves 
as a signal molecule in the PHO regulatory cascade [226].  The VIP1 and KCS1 genes are 
two inositol pyrophosphate synthases that produce IP7 [227, 228].  Interestingly, the 4/6 
PP-IP5 form of IP7 generated by VIP1, but not 5PP-IP5 produced by KCS1, is a regulator 
of the Pho80-Pho85 CDK complex [229].  This is interesting because the KCS1, but not 
the VIP1, was identified in the genomic screen described above.  Regardless, upon 
phosphate starvation, IP7 levels are increased and required for the Pho81 inhibition of 
Pho80-Pho85 complex even though Pho81 is constitutively associated with the CDK 
complex [230].  
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Fig. 3.  Schematic depiction of regulation of PHO5 expression in response to phosphate 
levels.   
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Fig. 4. A model for PHO5 nucleosome disassembly during activation [213-215]. 
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1.3.3 Inositol/Choline Mediated Transcriptional Regulation  
In S. cerevisiae, genes encoding phospholipid synthesizing enzymes are regulated by 
availability of soluble precursors, inositol (I) and choline (C).  When extracellular levels 
of these precursors become limiting [231, 232], a transcriptional heterodimeric complex 
composed of the Ino2p:Ino4p bHLH proteins binds to a conserved cis-acting upstream 
activating sequence known as UASINO and activates transcription of many genes 
encoding phospholipid, fatty acid, and sterol biosynthetic enzymes [233, 234].  In the 
presence of IC, expression of these genes is repressed to varying degrees.  INO1 which 
encodes inositol-3-phosphate synthase, is the most highly repressed gene with at least 30-
fold repression in response to IC [235].  Ino4p is required for binding Ino2p to the 
UASINO element which enables the transcriptional activation domain of Ino2p to activate 
transcription of target genes such as INO1.  Ino2p recruits Snf1p (histone kinase) to the 
promoter, which phosphorylates Ser10 of histone H3 [236].  The phosphorylated H3 
binds the SAGA complex, which acetylates Lys 14 on histone H3 and also recruits the 
TATA-binding protein (TBP) [236, 237].  There are other chromatin remodelers involved 
in the activation.  Ino2p recruits Ino80p to the INO1 promoter, which then recruits 
SWI/SNF to perform chromatin remodeling of the promoter [238, 239]. 
A previous study showed that an INO2-cat reporter gene is also regulated by IC.  
Addition of IC repressed INO2-cat gene expression 12-fold [12, 240].  This regulation 
required both the INO2 and INO4 genes, showing that INO2 is regulated in the same 
manner as its target genes [12].  However, an INO4-cat gene was expressed constitutively 
with respect to IC and did not require the INO2 gene [241].  Regulation of INO1 
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expression by IC is not required for regulation of its target genes but is required for the 
degree of derepression [242, 243]. 
Opi1p is a repressor involved in the regulation of INO1.  The mechanism for 
regulation by Opi1 has been defined (Fig. 5).  In absence of IC, Opi1p is tethered in the 
ER membrane by Scs2p [244, 245].  Addition of IC, results in depletion of phosphatidic 
acid (PA) and triggers the translocation of Opi1p from the cytoplasm to the nucleus [246],  
where it interacts with Ino2p and inhibits its activity.  Opi1p also represses expression of 
the INO2 gene [247].  The OPI1 locus was identified in a screen for mutants that over 
produce and excrete inositol (Opi-) into the growth medium in the absence of IC [248].  It 
was reported that OPI1 expression is also downregulated in the presence of IC.  The 
pattern of OPI1 mRNA expression in a northern blot analysis therefore resembles that of 
INO1 [249].  In the same study, it was found that Ino2p, Ino4p and Opi1p were necessary 
for regulation of OPI1 [250]. The OPI1 promoter region contains an E-box (CATATG, -
203bp to -196bp) which is responsible for the IC-mediated regulation [250].  
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Fig. 5. Schematic depiction of INO1 regulation. 
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1.3.4 Retrograde Regulation via the RTG Pathway 
Retrograde regulation refers to regulation of nuclear-encoded gene in response to the 
functional status of the mitochondria.  A well-known example is CIT2 (Fig. 6), which 
encodes a peroxisomal citrate synthase and is induced in response to the absence of 
mitochondria [251, 252].  The bHLH proteins Rtg1p and Rtg3p were identified as 
positive regulators of CIT2 gene using a CIT2-lacZ reporter in a mitochondria-deficient 
(ρ0) background [199].  RTG1 is expressed constantly while RTG3 mRNA is derepressed 
in a ρ0 strain [17, 198].  Rtg3p is responsible for transcriptional activation and recruited 
by Rtg1p to the UAS elements in the CIT2 promoter [253].  Two cis-elements required 
for CIT2 induction are defined by the sequence, 5’-GGTCAC-3’, which is different from 
a typical E-box sequence (CANNTG). This sequence is referred to as the R-box. 
Regulation by the Rtg1p:Rtg3p heterodimer involves shuttling between the nucleus and 
the cytoplasm (Fig. 6).  In respiratory-competent (ρ+) cells, in which CIT2 expression is 
repressed, Rtg1p:Rtg3p exist largely in the cytoplasm.  Conversely, in ρ0 petite strains, in 
which CIT2 expression is induced, they localize to the nucleus [16].  Cytoplasmic Rtg3p 
is multiply phosphorylated and becomes partially dephosphorylated when localized to the 
nucleus [16].  Rtg2p, which is cytoplasmic in both ρ+ and ρ0 cells, is required for the 
dephosphorylation and nuclear localization of Rtg3p [16]. 
Several upstream components of RTG regulatory cascade have been identified but the 
precise regulatory signals remain unclear.  It was proposed that both TOR (Target of 
rapamycin) and nutrient-based signals converge on Mks1p, which directly inhibits 
Rtg1p:Rtg3p [254].  However, later evidence showed that retrograde response is 
separable from TOR regulation of RTG-responsive genes [255]. 
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The downstream target genes of the RTG regulatory cascade have been identified by 
microarray hybridization.  Respiratory deficiency induces a set of genes associated with 
both peroxisomal activities and metabolite-restoration (anaplerotic) pathways that would 
alleviate the complete loss of the tricarboxylic acid cycle [256].  These studies also 
suggest that besides the RTG cascade there are other pathways for retrograde response 
[256].  
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Fig. 6. Schematic depiction of CIT2 regulation 
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1.4 Cross-regulation between Yeast bHLH Proteins 
      Our lab has identified a network of bHLH protein interactions in yeast where Ino4p is 
a central player [9].  Ino4p acts like the mammalian bHLH protein Max.  Max is known 
to form multiple dimers with Myc, Mad, and Mxi1 [10].  Ino4p has been shown to also 
work as a hub to dimerize with several bHLH proteins that regulate diverse cellular 
processes [9] (Fig. 7).   
      In one of the studies performed in our lab, we tested all nine S. cerevisiae bHLH 
proteins for regulation the enolase-encoding gene ENO1 [209].  ENO1 was known to be 
activated by Sgc1p and this study showed that expression of an ENO1-lacZ reporter was 
also regulated by the other eight bHLH proteins.  ENO1-lacZ expression was also 
repressed by growth in IC-containing medium [209].  Regulation by Sgc1p, Ino2p, Ino4p, 
and Cbf1p and repression by IC required three distal E boxes, E1, E2, and E3 [209].   
The S. cerevisiae CIT2 gene, which encodes citrate synthase, functions in the TCA and 
glyoxylate cycles.  It was previously known to be induced by Rtg1p:Rtg3p in response to 
mitochondrial damage [254] by binding two R-boxes (modified E-boxes) in the CIT2 
promoter [199].  A similar study in our lab tested the ability of all nine S. cerevisiae 
bHLH proteins to regulate the CIT2 gene [257] and showed that expression of CIT2–lacZ 
reporter was induced in a ρ0 strain by the presence of inositol via the Ino2p:Ino4p bHLH 
proteins [257].  Promoter mutations revealed that inositol induction required a distal E-
box in the CIT2 promoter [257].  The Hms1p and Sgc1p bHLH proteins also play 
important roles in repression of CIT2–lacZ expression [257]. 
Likewise, a recent report by our lab discovered the requirement of a third bHLH 
protein, Cbf1p, for the complete derepression of INO1 transcription [258].  The study 
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found that Cbf1p regulates INO1 transcription by binding to sites distal to the INO1 
promoter and encompassing the upstream SNA3 open reading frame and promoter [258].  
The binding of Cbf1p requires Ino2p:Ino4p binding to the UASINO sites in the INO1 
promoter and vice versa, suggesting a cooperative mechanism [258].  Furthermore, Cbf1p 
binding to the upstream sites was required for the binding of the ISW2 chromatin-
remodeling complex at the Ino2p:Ino4p binding sites on the INO1 promoter [258].  
Consistent with this, ISW2 was also required for the complete derepression of INO1 
transcription [258].  Collectively, these results support the model that bHLH proteins 
coordinate different biological pathways via multiple mechanisms. 
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Fig.7. Schematic depiction of examples of cross-regulation between yeast bHLH 
proteins. Solid arrows stands for direct reaction and dotted arrows for indirect reaction. 
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CHAPTER 2  
EXPERIMENTAL MATERIALS AND PROCEDURES 
 
2.1 Strains, Media, and Growth Conditions  
Escherichia coli DH5α cells (Invitrogen, Carlsbad, CA) were grown in LB medium at 
37°C.  LB medium was composed of 10% (w/v) Bacto-tryptone, 5% (w/v) yeast extract, 
10% (w/v) NaCl and supplemented with 50 μg/ml Ampicillin for plasmid selection.  
The S. cerevisiae strains used in this study were BY4742 (ρ+) (MATα his3∆1 leu2∆0 
met15∆0 lys2∆0 ura3∆0) and isogenic strains containing pho4Δ, ino2Δ, ino4Δ, rtg1Δ, 
rtg3Δ, sgc1Δ, cbf1Δ, hms1Δ, and ygr290wΔ alleles [259].  The ρ0 (lacking mitochondria) 
derivatives were previously created in the Lopes lab by several passages of the ρ+ strains 
through YEPD medium (2% yeast extract, 1% peptone, 2% glucose) containing 15–20 
mg/ml ethidium bromide [260] and then checked for the presence of mitochondrial DNA 
by staining with 4’,6’-diamino-2-phenylindole (DAPI) [257].  Yeast strains were grown 
at 30°C in YEPD medium (1% (w/v) yeast extract, 2% (w/v) peptone and 2% (w/v) 
glucose) or complete synthetic medium [261] lacking uracil for selection of reporter 
plasmid.  Complete synthetic media contained either low Pi (0.22 mM KH2PO4 and 20 
mM KCl) or high Pi (11 mM KH2PO4) and/or lacked inositol and choline (I-C-) or 
contained 75 μM inositol and 1 mM choline (I+C+) [258].  In the case of the ino2∆ and 
ino4∆ mutants, a minimal amount of inositol was supplemented into I-C- medium ([I] = 
10 µΜ) in order to allow these inositol auxotrophs to grow.  This concentration of 
inositol still allows for derepression of phospholipid biosynthetic genes [12]. 
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For Chromatin Immunoprecipitation (ChIP) experiments, endogenously epitope-
tagged yeast strains (INO2:TAP and INO4:TAP) were obtained from Open Biosystems 
(Huntsville, AL) [262].  Derivatives of the TAP-tagged strains were constructed by 
deleting the PHO4 by homologous recombination of the KanMX4 cassette in place of the 
ORF (INO2-TAP shown as an example in Fig. 8).  The PHO4::KanMX4 locus was 
amplified from genomic DNA from the viable yeast deletion collection alleles [259] 
using primers Pho4-100 to -56 F and Pho4+1039R (Table 1).  The resulting 1864 bp PCR 
product containing 100 bp upstream and downstream of the ORF was purified and 
transformed into INO2 TAP-tagged or INO4 TAP-tagged strains using the Yeast Maker 
transformation kit (Clontech, Mountain View, CA).  Transformants were selected on 
YEPD + G418 plates and the deletion allele was confirmed by sequencing of relevant 
PCR products.  
Strains containing specific PHO5 E-box mutants were constructed using a three-step 
approach as follows (Fig. 9) [263, 264].  The first step was to generate DNA fragments 
with mutated PHO5 E-boxes. A 600 bp fragment of the WT PHO5 promoter was 
amplified by PCR amplified using primers Pho5 -600 F and Pho5 +100 R (Table 1) and 
cloned into pGEM-T (Promega, Madison, WI). Mutagenesis reactions were carried out 
using the QuickChange® XL-Site-directed Mutagenesis Kit (Stratagene, LaJolla, CA) 
and created restriction sites in place of the E-boxes. E-box -194 was mutated using 
primer pairs Pho5E194mutF and Pho5E194mutR (Table 1). E-boxes -247 and -356 were 
sequentially mutated in the same plasmid using primers Pho5E247mutF and 
Pho5E247mutR followed by Pho5E356mutF and Pho5E356mutR (Table 1).   
Mutagenized E-boxes fragments were PCR amplified using the Pho5 -600 F and Pho5 
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+100 R primers from the relevant pGEM-T derivatives. The second step is to prepare the 
INO2 TAP-tagged strain. A 600 bp region of the PHO5 promoter in an INO2 TAP-
tagged strain was replaced with a URA3 cassette.  Primers Pho5-545Ura3 F and 
Pho5+45Ura3 R were used to amplify a 1000 bp fragment from YEp357R plasmid [265] 
containing a URA3 selectable marker.  To disrupt the PHO5 promoter, the PCR product 
was transformed into a INO2 TAP-tagged strain and transformants were selected on Ura- 
plates.  In the third step, the PCR amplicants of the mutated PHO5 E-boxes were co-
transformed with pRS313 [266] into the INO2 TAP-tagged strain carrying the URA3 
cassette in place of the PHO5 promoter.  Transformants were selected on His- media 
(pRS313) and replicated to 5’FOA.   Strains were confirmed by sequencing and 
restriction digestion. 
The PHO4 promoter (1000 bp) was amplified using the PHO4-cat primers (Table 1) 
and fused to the cat reporter gene.  The 1 kb PCR product was first cloned into pGEM®-T 
(Promega), sequenced, excised with BamHI and BglII, and ligated into a BamHI site in 
pBM2015 [267].Yeast strains containing the promoter-cat reporter integrated in single 
copy at the GAL4 locus were generated by transformation as previously described 
[242](Fig.10). 
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Fig. 8. Construction of pho4Δ:: INO2-TAP strain  
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Fig. 9. Construction of PHO5 E-box Mutants in INO2-TAP strain 
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Fig. 10. Strategy for creating strains with a genomic PHO4-cat fusion reporter. 
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2.2 Plasmid Construction  
Plasmid YEp357R-PHO5-lacZ contained 1000 bp of upstream sequence of the PHO5 
ORF and the first codon fused in-frame with the lacZ reporter gene in plasmid YEp357R 
[265] and a URA3 selectable marker.  The insert was amplified from yeast genomic DNA 
(Invitrogen) by PCR using primers PHO5 F and PHO5 R (Table 1).  The 1000 bp PCR 
product was first ligated into pGEM®-T (Promega, Madison, WI), sequenced, excised by 
digestion with EcoRI and HindIII and cloned into YEp357R. 
For complementation assays, plasmid pRS315 (LEU2 marker) [266] containing INO2 
and INO4 promoters and ORFs have been previously described [209].  For 
complementation of pho4Δ, plasmid pRS313-13myc-PHO4 was generously provided by 
Dr. Dennis Wykoff [268].  
The pGEM®-T-PHO5 described above was used as a template for construction of E-
box point mutations in the PHO5 promoter.  Six single E-box variants and combinations 
of relevant double and triple variants in the PHO5 promoter (positioned at -145, -194, -
247, -343, -356, and -668 relative to the ORF AUG) were created using the 
QuickChange® XL-Site-directed Mutagenesis Kit (Stratagene, LaJolla, CA).  In each case, 
the E-box mutation created a restriction site (primer pairs are listed in Table 1 with 
restriction site and location of E-box).  The mutant PHO5 promoters were cloned into 
YEp357R as described above.   
2.3 β-Galactosidase Assay  
 
Yeast strains were grown in 5 ml of appropriate medium to mid-log phase (70-90 
units at OD600) and pelleted by centrifugation at 5,000 X g for 10 min.  The pellet was 
resuspended in 200 μl of β-gal assay buffer (20% glycerol, 0.1 M Tris-HCl, pH8.0, 1 mM 
40 
DTT, and 1 mM PMSF), transferred to a sterile 1.5 ml microcentrifuge tube, and stored at 
-80°C.  Cells were thawed on ice and 100 μl of glass beads (0.45 mm) were added.  Cells 
were lysed by vortexing 8 x 20 sec, placing tubes on ice between vortexing.  Cellular 
debris was removed by centrifugation at 14,000 rpm for 10 min at 4°C.  The supernatant 
was transferred to a 1.5 ml microcentrifuge tube.  The β-gal activity reaction mixtures, 
containing 20 μl of yeast extract and 80 μl of β-gal assay buffer, were incubated for 5 min 
at 28°C and 40 μl of ONPG (4 mg/ml) was added to start the reaction.  The optical 
density of the solution was measured at O.D. = 420 nm at 12 seconds intervals over a 30 
min span.  Protein concentrations were quantified using a BioRad Protein Assay (BioRad, 
Rockville Center, NY).  Both the β-gal activity reactions and the protein concentrations 
were measured using a VERSAmaxTM Tunable Microplate Reader (Molecular Devices) 
and the SOFTmax®PRO software (Molecular Devices, Sunnyvale, CA).  Units of β-gal 
activity = OD420/min/mg total protein x 1000. 
2.4 Chloramphenical Acetyltransferase (CAT) Assay  
Cat assays were performed as described previously [12, 267].  Units of Cat activity 
were defined as percent conversion of [14C]-chloramphenicol/total amount of protein 
(mg)/hour.  
2.5 Quantitative PCR  
Total yeast RNA was isolated using the RNeasy® Mini Kit (Qiagen, Valencia, CA).  
RNA was reverse-transcribed to cDNA by amplifying with random primers using 
Superscript™ III Reverse Transcriptase (Invitrogen). 
PHO5 cDNA was quantified by real-time PCR using an Mx3000P®QPCR 
thermocycler and MxPro™QPCR Software (Stratagene).  Primers specific to the PHO5 
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ORF (qPCR primers in Table 1) were designed using the Primer3 software 
(http://frodo.wi.mit.edu/).  Primer and template DNA concentrations were optimized.  
The amplification reactions with SYBR® Green (Qiagen) were performed using the 
following program: 1 cycle of 50 °C for 2 min and 95°C for 10 min, followed by 40 
cycles of 95°C for 15 sec, 60°C for 1 min.  The data were calibrated using the TCM1 
gene (qPCR primers in Table 1). 
2.6 Chromatin Immunoprecipitation  
Epitope-tagged yeast strains (INO2:TAP and INO4:TAP) and a WT strain 
transformed with pRS313-13myc-PHO4 [268] were grown in 100 ml of appropriate media 
to O.D. 600 nM = 0.6 to 0.8 and 2.3 ml of 37 % formaldehyde was added.  The mixture 
was placed in a shaker for 15 min, 7.5 ml of 2.5 M glycine was added and the mixture 
was incubated for 5 min at RT.  Cells were pelleted by centrifugation for 5 min at 3500 
rpm at 4°C and the pellet was washed twice with ice-cold TBS (100 mM Tris/HCl pH7.5, 
0.9% NaCl).  Cell pellets were resuspended in 500 μl of FA lysis buffer (50 mM HEPES 
pH7.5, 150 mM NaCl, 1mM EDTA, 1% Triton X-100, 0.1% NaDeoxycholate, 0.1% SDS) 
with 2 mM PMSF.  An equal amount of glass beads were added and the cells were 
broken by vortexing continuously for 40 minutes at 4°C.  Cell lysates were collected by 
centrifugation for 15 min at 14,000 rpm at 4°C and resuspended in 1 ml ice-cold FA lysis 
buffer.  Samples were sonicated 20 x 20 seconds (placing on ice for 1-2 min between 
pulses) on a setting of 6 in a Sonic Dismembrator Model 100 (Fisher Scientific, 
Pittsburgh, PA).  The samples were centrifuged at highest speed in a microcentrifuge at 
4°C and the supernatant was saved for immunoprecipitation reactions.  For 
immunoprecipitations, 800 μl aliquot of cell extracts were mixed with relevant antibodies 
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with the remainder saved as input (IP) sample.  For the PHO4-Myc strain, 1 μl mouse 
anti-Myc antibody (9E10; 200 μg/ml) (Santa Cruz Biotechnology, Santa Cruz, CA) was 
added and the sample was incubated for 4 hours at RT and then 40 μl Dynabeads Protein 
A (Invitrogen) were added.  For INO2-TAP and INO4-TAP, 40 μl of IgG sepharose 
beads (GE Healthcare, Uppsala, Sweden) were used.  The solutions were incubated for 
one hour at RT on a nutator.  The beads were pelleted by centrifugation and washed 
seven times: two times with 1 ml FA lysis buffer with 0.05% SDS; two times with 1ml 
FA lysis buffer with 500 mM NaCl and 0.05% SDS; two times with 1 ml ChIP wash 
buffer (10 mM Tris/HCl pH8.0, 0.25 M LiCl, 1 mM EDTA, 0.5% Nonidet P-40, 0.5% 
NaDeoxycholate, with 0.05% SDS); and once with TE buffer.  Beads were incubated 
with 125 μl ChIP Elution Buffer (50 mM Tris/HCl pH7.5, 10 mM EDTA, 1% SDS) for 
10 min at 65°C.  The beads were washed with 125 μl TE and 5 μl of RNase A (5 μg/μl) 
was added to each sample and incubated at 37°C for 10 min.  The samples were treated 
with 5 μl of Proteinase K (20 mg/ml) and 2.5 μl of 10% SDS for 2 hours at 42°C and 
DNA was purified using a ChIP DNA Clean and Concentrator Kit (Zymo Research, 
Irvine, CA). For qPCR IP and ChIP samples were diluted 100 or 10 times, respectively.  
Primers for qPCR are listed in Table 1 (noted as ChIP) along with primers for negative 
control (PHO5 ORF), INO1 positive control, and calibrator (TCM1 ORF).  
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Table 1. Oligonucleotides used in this study 
Designation Sequence  
PHO5 F 5’-AAGCTTTAAATACAATGTTCC-3’ 
PHO5 R 5’-GAATTCAACATTGGTAATCTC-3’ 
PHO5 qPCR F 5'-CATGTCCTGCTTGGGACTAC-3' 
PHO5 qPCR R 5'-CAAATGCACACCACGAGAATA-3' 
TCM1 qPCR F 5'-AAGAAGGCTCATTTGGCTGA-3' 
TCM1 qPCR R 5'-AACACCTTCGAAACCGTGAC-3' 
PHO5-BglII-145F 5'-GGTCACCTTACTTGGCAAGGCATATACCAGATCT 
GGATAAGGGTAAACATCTTTGAATTGTCG-3' 
PHO5-BglII-145R 5'-CGACAATTCAAAGATGTTTACCCTTATCCAGATCT 
GGTATATGCCTTGCCAAGTAAGGTGACC-3' 
PHO5-SacII-194F 5'-CTGGTCCCTGTTTTCGAAGAGATCGCCGCGGCCA 
AATTATCAAATTGGTCACCTTAC-3' 
PHO5-SacII-194R 5'-GTAAGGTGACCAATTTGATAATTTGGCCGCGGCG 
ATCTCTTCGAAAACAGGGACCAG-3' 
PHO5-Narl-247F 5'-GAATCGATACAACCTTGGCACTCAGGCGCCGGAC 
TAGCACAGACTAAATTTATGATTC-3' 
PHO5-Narl-247R 5'-GAATCATAAATTTAGTCTGTGCTAGTCCGGCGCC 
TGAGTGCCAAGGTTGTATCGATTC-3' 
PHO5-XhoI-343F 5'-GCACGTTTTCGCATAGAACGCTCGAGCACAATGC 
CAAAAAAAGTAAAAGTGATTAAAAGAG-3' 
PHO5-XhoI-343R 5'-CTCTTTTAATCACTTTTACTTTTTTTGGCATTGTGC 
TCGAGCGTTCTATGCGAAAACGTGC-3' 
PHO5-SmaI-356F 5'-GTCTGCACAAAGAAATATATATTAAATTAGCCCG 
GGTTCGCATAGAACGCAACTGCACAATGCC-3' 
PHO5-SmaI-356R 5'-GGCATTGTGCAGTTGCGTTCTATGCGAACCCGGG 
CTAATTTAATATATATTTCTTTGTGCAGAC-3' 
PHO5-XbaI-668F 5'-CCGCTCCTTCTAATAATCGCTTGTATCTCTATCTA 
GATTCTATTTACTGACCGAAAGTAGCTCGC-3' 
PHO5-XbaI-668R 5'-GCGAGCTACTTTCGGTCAGTAAATAGAATCTAGA 
TAGAGATACAAGCGATTATTAGAAGGAGCGG-3' 
TCM1 ORF CHIP F 5’-TTGTATTGGTGCTTGGCATC-3’ 
TCM1 ORF CHIP R 5’-TCTGTCGAAGCTGGTAGCAC-3’ 
PHO5 ORF CHIP F 5’-AACCAGTTTCGCCGTTTTTA-3’ 
PHO5 ORF CHIP R 5’-CGTAGTCCCAAGCAGGACAT-3’ 
INO1-383 CHIP F 5’-ATTGCCTTTTTCTTCGTTCC-3’ 
INO1-383 CHIP R 5’-CATTCAACACTTTCGATTCC-3’ 
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PHO5 E194+E145 
CHIP F 
5’ ACTAAATTTATGATTCTGGTCCCTGT 3’ 
PHO5 E194+E145 
CHIP R 
5’ CATCAGCGCTTATATACGTTTCA 3’ 
PHO5 E343+E247 
CHIP F 
5’ TAGAACGCAACTGCACAATG 3’ 
PHO5 E343+E247 
CHIP R 
5’ TCTTCGAAAACAGGGACCAG 3’ 
PHO5 E356 CHIP F 5’ AATGCGCAAATATGTCAACG 3’ 
PHO5 E356 CHIP R 5’ ATGCGAAAACGTGCTAATTT 3’ 
PHO5 E356 CHIP FII 5’-AGCGCTTTTTCTTTGTCTGC-3’ 
PHO5 E668 CHIP F 5’ CGAGAAACGTGACCCAACTT 3’ 
PHO5 E668 CHIP R 5’ TGTAAAGAGAGCGTGCGACA 3’ 
PHO4-cat F 5’GGATCCTGCGATGTTATTGT 3’ 
PHO4-cat R 5’AGATCTGACTTTCTGCTACT 3’ 
Pho4 -100 to -56F 5’-ACCATAGAAAAATGTATATAACCAGGGAAGAAG  
TCATGCTTCGG-3’ 
Pho4 +1039R 5’-TGGGCCACTTTCCAGCAAAGCG-3’ 
Pho5 -600F 5’-CGCTAATAGCGGCGTGTCGCAC-3’ 
Pho5 +100R 5’-TGGGTACCAATCTTGTCGACAT-3’ 
Pho5E247MutF 
(BglII) 
5’-TTGAATAGGCAATCTCTAAATGAATCGATACAAC  
CTTGGCACTCAAGATCTGGACTAGCACAGACTAAAT  
TTAT-3’ 
Pho5E247MutR  
(BglII) 
5’-ATAAATTTAGTCTGTGCTAGTCCAGATCTTGAGTG  
CCAAGGTTGTATCGATTCATTTAGAGATTGCCTATTC 
AA-3’ 
Pho5E194MutF  
(NheI) 
5’TCTGGTCCCTGTTTTCGAAGAGATCGGCTAGCCCA  
AATTATCAAATTGGTCACCTTAC-3’ 
Pho5E194MutR 
(NheI) 
5’-GTAAGGTGACCAATTTGATAATTTGGGCTAGCCG  
ATCTCTTCGAAAACAGGGACCAGA-3’ 
Pho5E356MutF  
(XbaI) 
5’-GCGCTTTTTCTTTGTCTGCACAAAGAAATATATAT  
TAAATTAGTCTAGATTCGCATAGAACGCAACTGCAC  
AATGCCAAA3’ 
Pho5E356MutR  
(XbaI) 
5’-TTTGGCATTGTGCAGTTGCGTTCTATGCGAATCTA 
GACTAATTTAATATATATTTCTTTGTGCAGACAAAGA 
AAAAGCGC-3’ 
Pho5-545Ura3 F 5’-CAAGGATCCGAAAGTTGTATTCAACAAGAATGCG  
CAAATATGTCATAGCTTTTCAATTCAATTCA-3’ 
Pho5+45Ura3 R 5’-
GGCCAAAGAAGCGGCTAAAATTGAATAAACAACA 
GATTTAAACATGTTTTGCTGGCCGCATCTTC-3’ 
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CHAPTER 3 
RESULTS 
3.1 PHO5 is Repressed by Inositol and Regulated by Ino2p and Ino4p  
3.1.1 PHO5 is Regulated by Multiple bHLH Proteins 
 
3.1.1.1 PHO5-lacZ Assay Identified bHLH Protein Regulators 
 
It is well known that PHO5 expression is induced in response to phosphate depletion 
and that induction requires Pho4p, a well-studied bHLH protein [7, 15, 217, 269].  Recent 
studies reveal that the INO1, ENO1 and CIT2 genes respond to multiple bHLH proteins 
[209, 257, 258].  To determine if other bHLH proteins affected PHO5 expression we first 
assayed a PHO5-lacZ reporter (driven by 1 Kb of the PHO5 promoter) in 9 yeast bHLH 
knock-out strains (Fig. 11A).  Strains were grown in low (Low Pi) and high (High Pi) 
phosphate media, which are known to regulate PHO5 expression [15, 217, 269], as well 
as in the presence (I+C+) and absence (I-C-) of inositol/choline, which regulate Ino2p 
levels [240].   
As expected, PHO5-lacZ expression was induced in low phosphate medium, 
regardless of the presence or absence of inositol/choline, and this induction required 
Pho4p (Fig. 11A) [2, 270].  Surprisingly, PHO5-lacZ expression in the wild type strain 
was also repressed by inositol/choline (Fig. 11A, compare green bars with red bars).  
Consistent with the role of Ino2p:Ino4p dimer, inositol regulation (but not phosphate 
regulation) was significantly dampened in ino2Δ and ino4Δ strains relative to the wild 
type strain (Fig. 11A). The PHO5-lacZ results also showed that cbf1Δ, sgc1Δ and 
ygr290wΔ yielded reduced expression under all growth conditions while the rest of the 
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knockout strains behaved similar to the wild type strain (Fig. 11A).  The remainder of 
this study focused on Ino2p and Ino4p because they are extensively studied regulators 
and because the PHO5-lacZ reporter was also repressed by inositol/choline. 
3.1.1.2 PHO5 Transcripts Levels Quantified by qPCR 
To ensure that the Ino2p:Ino4p mediated inositol regulation of PHO5-lacZ expression 
was physiologically relevant, PHO5 transcript levels were quantified by qPCR in WT, 
pho4Δ, ino2Δ, and ino4Δ strains.  Consistent with the PHO5-lacZ results (Fig. 11A), 
inositol/choline also repressed PHO5 transcription in the presence of low Pi, however it 
was not observed in the high Pi media (Fig. 11B).  This may be because PHO5 
transcription was more reduced than PHO5-lacZ expression in the high Pi media 
(compare Fig. 11A to 11B).  Not surprisingly, PHO5 mRNA was nearly undetectable in 
the pho4Δ strain. Consistent with the PHO5-lacZ results, inositol/choline regulation was 
also eliminated in the ino2Δ and ino4Δ strains (Fig. 11B). 
 
 
 
 
 
 
 
 
 
 
47 
Fig. 11. PHO5-lacZ expression is regulated by phosphate as well as inositol.  (A) A 
plasmid containing a PHO5–lacZ reporter gene was transformed into a wild-type strain 
(BY4742) and isogenic bHLH knock-out strains.  PHO5–lacZ derived β–galactosidase 
activity was assayed from cultures grown in either low phosphate (Pi low) or high 
phosphate (Pi high) and/or the absence (I−C−) or presence of inositol and choline (I+C+).  
In the case of the ino4Δ and ino2Δ strains, the I−C− medium contained 10 μM inositol to 
allow for growth of these inositol auxotrophs.  (B) Quantification of PHO5 transcript 
levels in WT, pho4Δ, ino2Δ, and ino4Δ isogenic strains grown to mid-log phase under the 
four growth conditions described above.  PHO5 transcript levels were quantified by 
qPCR and normalized to TCM1 transcript levels.  (C) A WT transformant harboring the 
PHO5-lacZ reporter was grown under different combinations of inositol (I) and choline 
(C) and assayed for β–galactosidase activity.  The data represent means and standard 
errors of the means from at least three different experiments. 
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3.1.1.3 Complementation Tests to Confirm Phenotype of the bHLH Knockout 
Strains 
Complementation tests were conducted to confirm that the PHO5-lacZ expression 
phenotypes of pho4Δ, ino2Δ, and ino4Δ were indeed due to these mutant alleles.  The 
pho4Δ mutant strain was co-transformed with YEp357R-PHO5-lacZ and either pRS313 
or pRS313-PHO4 (contains the PHO4 promoter and ORF).  PHO5-lacZ expression was 
restored to wild type levels in the pho4Δ knock-out strain harboring pRS313-PHO4 (Fig. 
12A).  Likewise, we tested for complementation of the ino2Δ and ino4Δ PHO5-lacZ 
phenotype and inositol auxotrophy by transforming with pRS315 or pRS315-INO2 or 
pRS315-INO4.  The results showed that the inositol auxotrophy was complemented (Fig. 
12B) and that PHO5-lacZ expression was restored to wild type levels when the ino2Δ and 
ino4Δ strains were transformed with the cognate plasmid (Fig. 12C). 
3.1.2 Inositol but not Choline Plays a Major Role in PHO5-lacZ Regulation 
In the case of phospholipid biosynthetic genes, it is clear that choline has no effect on 
its own but enhances repression by inositol [209, 271, 272].  However, a genome-wide 
expression study identified a much larger set of IC-regulated genes that respond to 
inositol and/or choline [273].  To determine how PHO5-lacZ regulation is affected by 
these precursors, different combinations of inositol and choline in the medium were 
tested (Fig. 11C).  These data show that PHO5-lacZ expression is repressed by inositol 
and that choline does not play a prominent role in this regulation, which is reminiscent of 
the phospholipid biosynthetic genes. 
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Fig.12. Complementation of the pho4Δ, ino2Δ, and ino4Δphenotypes.  (A) The WT  
and  pho4Δ  strains  were  co-transformed  with  the  PHO5-lacZ  reporter  plasmid  
and/or pRS313  or  pRS313-13myc-PHO4  plasmid. Transformants were grown under the 
four conditions described above and assayed for β-galactosidase activity. (B) The WT, 
ino2Δ,  and  ino4Δ  strain  were  transformed  with  either  pRS315  and/or  pRS315-
INO2/INO4 plasmids.  Untransformed and transformed strains were replicated onto 
media containing (I+) or lacking (I-) inositol.   (C) Similarly, the WT, ino2Δ, and ino4Δ  
strains  were  co-transformed  with  the  PHO5-lacZ  plasmid  and/or  either  pRS315  or 
pRS315-INO2/INO4 plasmids.  Transformants were grown in either low Pi or high Pi in 
the presence of inositol and choline  (because  the  ino2Δ and  ino4Δ mutants are  
inositol auxotrophs)  and  assayed  for  β-galactosidase  activity.  The data represent 
means and standard errors of the means from at least three different experiments. 
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 3.1.3 The Absence of Mitochondria has no Effect on PHO5-lacZ 
Expression  
      Because bHLH proteins Rtg1p and Rtg3p are well known players in the mitochondria 
retrograde response, we also investigated whether the RTG pathway was coordinated 
with the PHO pathway.  The data showed that RTG1 and RTG3 were not required for 
regulation of PHO5-lacZ in the presence of mitochondria (Fig. 11A).  However, it was 
still necessary to test PHO5-lacZ expression in the absence of mitochondria using an 
isogenic set of ρ0 strains (generated in Lopes’ lab [257]).  Unlike CIT2 which is a target 
gene induced by Rtg1p/Rtg3p in the absence of mitochondria, PHO5-lacZ data show no 
evidence of induction in the absence of mitochondria (Fig. 13).  There were no significant 
changes in the PHO5-lacZ expression levels when comparing ρ+ (Fig. 11A) and ρ0 (Fig. 
13) in the otherwise WT background, so we did not pursue further research on the effect 
of mitochondria.  However, it is important to note that the Pho4p-regulated phosphate 
response and the Ino2p:Ino4p-regulated inositol response was observed even in the 
absence of mitochondria. 
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Fig.13. PHO5-lacZ expression was not regulated by the absence of functional 
mitochondria. A plasmid containing a PHO5–lacZ reporter gene was transformed into a 
ρ
0
 wild-type strain (BY4742) and isogenic bHLH knock-out strains. PHO5–lacZ 
derived β–galactosidase activity was assayed from cultures grown in either low 
phosphate (Pi low) or high phosphate (Pi high) and/or the absence (I−C−) or presence of 
inositol and choline (I+C+).  In the case of the ino4Δ and ino2Δ strains, the I−C− medium 
contained 10μM inositol to allow for growth of these inositol auxotrophs.  
 
PHO5-lacZ
 ρ0
0
500
1000
1500
2000
2500
WT
β
-
ga
la
ct
o
si
da
se
 
ac
tiv
ity
Low Pi I-C-
Hi Pi I-C-
Low Pi I+C+
Hi Pi I+C+
 
 
 
 
 
 
 
54 
3.2 bHLH Proteins Regulate Transcription through Three cis-Elements in 
the PHO5 Promoter  
3.2.1 Three E-boxes on PHO5 are Required for Regulation by bHLH 
Proteins 
It is well known that highly conserved amino acids in the basic region of bHLH 
proteins interact with nucleotides in a core sequence called the E-box, CANNTG [8, 10, 
274-276].  Examination of the PHO5 promoter identified 5 potential E-boxes: CATTTG 
(-145), CACATG (-194), CACGTG (-247), CAACTG (-343), and CATATG (-668) (Fig. 
14A).  The -247 E-box together with an E-box variant (CACGTT at -356) constitute 
UASp2 and UASp1 sites that bind Pho4p [210, 211] while the -194 E-box (UASp3) is a 
weaker binding site for Pho4p [2].  To determine the role of the E-boxes in bHLH-
mediated regulation of PHO5 expression, we mutated all six cis-elements individually in 
the PHO5-lacZ plasmid described above. The wild type and mutant promoter constructs 
were transformed into the WT strain, grown under the four conditions described above 
and assayed for β-gal activity (Fig. 14B). 
Consistent with published studies [211], the results showed that the E-box variant at -
356 and the E-box at -247 play major roles in PHO5 expression [211] (Fig. 14B).  In 
these two mutants, PHO5-lacZ expression was reduced in all four growth conditions 
although phosphate and inositol/choline regulation was still evident to some degree.  In 
addition, the -194 E-box (UASp3) mutant also yielded a reduction in PHO5-lacZ 
expression (Fig. 14B).  However, in this case the inositol/choline response was 
eliminated while the phosphate regulation was maintained suggesting that the response to 
inositol/choline is mediated through the UASp3 E-box (Fig. 14B).  The other E-box 
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mutants located at -668, -343 and -145 did show some minor media-specific differences 
relative to wild type but in general the overall patterns of expression were similar to wild 
type (Fig. 14B).  We also examined the effect of mutating the two main E-boxes (-
247and -356) as well as a triple mutant on PHO5-lacZ expression.  The -247/-356 double 
mutant combination yielded basal levels of expression that were not induced in low Pi or 
I-C- media, suggesting that the response to inositol is dependent on the normal response 
to Pi limitation (Fig. 14B).  As predicted from published studies [211], the -194/-247/-356 
triple mutant yielded even lower expression than the double mutant (Fig. 14B). 
3.2.2 Epistatic Analysis of E-box Mutants in the PHO5 Promoter and bHLH 
Mutants 
The E-box mutant results suggested that Ino2p/Ino4p-mediated inositol regulation of 
PHO5 expression occurred through the -194 E box.  In other studies, we have employed 
epistasis analysis to define bHLH:E-box interactions [209, 258].  Thus, here we used the 
same approach to test for interactions between the 3 relevant E-box mutants and the 
pho4Δ, ino2Δ, and ino4Δ mutants.  The results further strengthen the model that the 
inositol/choline response is mediated through the -194 E-box.  First, deleting the INO2 or 
INO4 genes had a mild effect on expression from the -194 mutant (relative to the WT 
strain), but had a more dramatic effect on the other two E-box mutants (Fig. 14C).  
Deleting the PHO4 gene decreased expression from all three E-box mutants, which is 
consistent with the fact that it binds all three E-boxes (Fig. 14C) [2, 210, 211].  
Experiments conducted with the -356/-247 double mutant and the -356/-247/-194 triple 
mutant also support the model that -194 is required for the response to inositol/choline 
(data not shown). 
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Fig.14. Regulation of PHO5–lacZ expression requires multiple promoter elements. (A) 
Schematic depicting the location of six potential regulatory elements in the PHO5 
promoter and 4 positioned nucleosomes. The filled boxes are known high affinity Pho4p 
binding sites [210, 211]and the shaded box is a low affinity Pho4p binding site [2]. T 
indicates the location of the TATA box. (B) Expression of the wild-type and six PHO5–
lacZ promoter mutants in a wild-type strain (BY4742). (C) Epistatic analysis of E-box 
mutations in the PHO5 promoter and relevant bHLH knock-out alleles. Individual PHO5 
E-box mutant promoters were assayed in WT and bHLH mutant strains. In the case of the 
ino4Δ and ino2 Δ strains, the I−C− medium contained 10µM inositol to allow for growth 
of these inositol auxotrophs. The data represent the mean +/- standard errors value of 
three independent transformants. 
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3.3 bHLH Proteins Regulate PHO5 by Direct Interaction with the Promoter 
Region  
3.3.1 Ino2p and Ino4p Interact with the PHO5 Promoter 
ChIP experiments were performed to elucidate if Ino2p and Ino4p interacted with the 
PHO5 promoter.  We probed for binding of Ino2p, Ino4p, and Pho4p to regions in the 
PHO5 promoter that included all of the potential E-boxes (Fig. 15A).  Since Pho4p is 
known to bind the PHO5 promoter [210, 211], we first tested for binding of 13Myc-
tagged Pho4p [268].  We tested for binding under the four growth conditions described 
above.  We used qPCR with primers to 4 regions upstream of the PHO5 ORF as well as 
the PHO5 ORF and the INO1 promoter.  Because of the proximity of some E-boxes, it 
was not possible to design primer sets to separate two sets of E-boxes (-145/-194 and -
247/-343). 
As expected, Pho4p-Myc did not yield significant occupancy in the PHO5 ORF (Fig. 
15B) or the INO1 promoter (Fig. 15C).  Also as expected, Pho4p-Myc was enriched in 
regions containing UASp1 (E-box -356), UASp2 (E-box -247), and UASp3 (E-box -194) 
in both low Pi media conditions (Fig. 15B).  The most significant occupancy was 
observed with primers covering UASp2 (E-box -247), and UASp3 (E-box -194).  There 
was also low Pi-specific occupancy in the regions containing UASp1 (E-box -356) and E-
box -668 (likely binding at UASp1) (Fig. 15B).  These results agree with previous reports 
in which UASp1 and UASp2 (E-boxes -356 and -247) were found to be high affinity 
binding sites for Pho4p and UASp3 was a low affinity site [2, 210, 211].  The -343/247 
primers identified the highest occupancy, which likely reflects binding at all three sites, 
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given their physical proximity. The 194/-145 primers also identified significant 
occupancy but less than observed with the -343/247 primers, likely due to fewer DNA 
fragments spanning the UASp1 element.  While Pho4p-Myc occupancy was relatively 
lower in the regions covering the UASp1 (-356), this occupancy was still significant (20-
fold) and likely reflected binding to only UASp1 given its distance from UASp2.  The 
results also showed increased occupancy at the low Pi condition, while inositol/choline 
did not have an effect which is consistent with the fact that inositol/choline did not affect 
PHO4 expression (discussed below). 
Next we quantified Ino2p-TAP and Ino4p-TAP occupancy at the PHO5 promoter 
using the same primers described above as well as the INO1 promoter as a positive 
control.  Consistent with published reports [258], the ChIP results showed enhanced 
occupancy for Ino2p-TAP and Ino4p-TAP at the INO1 promoter that was significantly 
enhanced under I-C- conditions (Fig. 15C).  Ino2p-TAP and Ino4-TAP occupancy was 
also increased in two regions of the PHO5 promoter under low Pi conditions (Fig. 15D 
and E).  The two primer sets covered the region that included UASp2 (E-box -247) and 
UASp3 (E-box -194) (Fig. 15D and E).  However, in the case of Ino2p-TAP and Ino4p-
TAP the presence of inositol/choline (in the low Pi medium) reduced the occupancy at the 
PHO5, which is consistent with the fact that Ino2p levels are reduced 12-fold in the 
presence of inositol/choline [240].  The occupancy pattern of Ino2p-TAP and Ino4p-TAP 
(Fig. 15D and E) were similar to the pattern of PHO5-lacZ expression (Fig. 11A) and 
PHO5 transcript levels (Fig. 11B).  However, Ino2p-TAP and Ino4p-TAP did not yield 
occupancy with the two most distal primer sets (E668 and E356) suggesting that they do 
not bind the UASp1 element (E-box -356).  Thus, Pho4p yielded low Pi-specific 
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occupancy with all primer sets whereas Ino2p:Ino4p occupancy was observed with only 
the two ORF proximal primer sets and was inositol/choline dependent.   
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Fig.15. Ino2p and Ino4p bind to the PHO5 promoter. (A)  Schematic depicting the 
location of six potential regulatory elements in the PHO5 promoter and of regions 
spanned by primers used in qPCR of ChIP analysis of bHLH proteins. The filled boxes 
are known high affinity Pho4p binding sites [210, 211] and the shaded box is a low 
affinity Pho4p binding site[2].  (B)  ChIP analysis of Pho4p-Myc binding to PHO5 
promoter.   ChIP was performed with a WT strain transformed with pRS313-13Myc-
Pho4 grown under the four conditions described above. The PHO5-ORF primers cover a 
region within the PHO5 coding sequence (negative control). The INO1 primers cover a 
region on the INO1 promoter and also serve as a negative control.  The ChIP levels were 
normalized to the input chromatin and calibrated to binding at the TCM1 ORF.  The data 
represent means and standard errors of the means from at least three different 
experiments.    (C) ChIP analysis of Ino2p-TAP, Ino4p-TAP and Pho4p-Myc binding to 
INO1 promoter. (D and E)  ChIP analysis of Ino2p-TAP and Ino4p-TAP (respectively) 
binding to PHO5 promoter. 
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3.3.2 Ino2p/Ino4p Binding to the PHO5 Promoter is Dependent on Pho4p 
Binding  
The results above suggest that inositol-mediated regulation via Ino2p:Ino4p occurs 
through the UASp3 element  (E-box  -194) and is dependent on Pho4p binding to the 
UASp1 and UASp2 elements.  This is also consistent with the current understanding that 
Pho4p binding recruits SWI/SNF and SAGA that displace the nucleosome covering the 
UASp2 and UASp3 region [213, 215].  To directly test this model, we quantified binding 
of TAP-tagged Ino2p and Ino4p to the PHO5 promoter in a strain deleted for the PHO4 
gene.  For this purpose, we used a set of primers for PCR that covered the UASp1 and 
UASp2 elements (E247+E356) and a second set that covers the UASp3 element 
(E194+E145) (Fig. 16A).  The results clearly show that TAP-Ino2p (Fig. 16B) and TAP-
Ino4p (data not shown) occupancy was eliminated in the pho4Δ mutant strain.  Binding in 
a PHO4 strain recapitulated results above (Fig. 16B and 15D).  
In another experiment, we mutated the three UASp elements in their native location 
and performed ChIP with TAP-Ino2p. Specifically, we created a strain with a double 
mutant of UASp1 (-356) and UASp2 (-247) since these are both known to be required for 
Pho4p binding and phosphate regulation; and a strain with a single mutant of UASp3 (-
194).  The results show that both the double mutant and the single mutant were 
completely defective in binding of the TAP-Ino2p (Fig. 16C).   Collectively, both sets of 
experiments support the model where Ino2p-Ino4p binding to the UASp3 is dependent on 
Pho4p binding to the UASp1 and UASp2 elements.   
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Fig.16. Ino2p and Ino4p bind to the PHO5 promoter is dependent on Pho4p binding.  (A)  
Schematic depicting the location of six potential regulatory elements in the PHO5 
promoter and of regions spanned by primers used in qPCR of ChIP analysis of  bHLH 
proteins.  The filled boxes are known high affinity Pho4p binding  sites  [210, 211] and 
the shaded box is a low affinity Pho4p binding site [2]. (B) ChIP analysis of Ino2p-TAP 
binding to PHO5 promoter in WT and pho4Δ strains grown under the four conditions 
described above.   The ChIP levels were normalized to the input chromatin and calibrated 
to binding at the TCM1 ORF.  The data represent means and standard errors of the means 
from at least three different experiments.    (C)  ChIP analysis of Ino2p-TAP binding to 
WT and PHO5 promoter mutants. 
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3.4 PHO4 Expression is Regulated by bHLH Proteins  
 
A possible contributing factor to the model for Ino2p/Ino4p-mediated regulation of 
PHO5 is that it might include indirect effects through regulating transcription of PHO4 
regulatory gene.  To test this possibility, we created WT and bHLH knock-out strains 
with a genomic PHO4-cat reporter.  In each of these cases, the reporter gene is stably 
integrated in single copy at the GAL4 locus.  The Cat assay results clearly showed that 
the presence of phosphate induces PHO4 expression in WT strain (Fig. 17).  This pattern 
of expression is in contrast to the PHO5 target gene that is repressed by high Pi (Fig. 
11A).  Curiously, the high Pi-mediated induction of PHO4-cat was eliminated in the 
pho4∆, ino2∆, and ino4∆ strains (Fig. 17).  The rest of the bHLH knock-out strains 
yielded a pattern that was identical to the wild type (data not shown).  These results 
suggest that Ino2p, Ino4p, and Pho4p are unlikely to regulate PHO5 through regulation of 
PHO4 expression because they affect these two genes in differentially.  The fact that 
Pho4p has the opposite effect on PHO4-cat expression (induction in high Pi rather than 
repression) and that Ino2p and Ino4p were also required for PHO4 induction suggests 
that regulation of PHO4 expression may involve a novel mechanism. 
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Fig. 17. PHO4-cat expression is induced by phosphate. A single copy of 1kb PHO4 
promoter fused with cat reporter gene was integrated at the GAL4 locus of WT strain. 
Stain was grown in either low phosphate (Pi low) or high phosphate (Pi high) and/or the 
absence (I−C−) or presence of inositol and choline (I+C+). The chloramphenicol 
acetyltransferase (CAT) activity was measured. The data represent the mean value of 
three independent transformants.  
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CHAPTER 4  
DISCUSSION 
The PHO5 gene is a well-studied example of regulation by a bHLH protein.  Our 
results provide the first evidence that bHLH proteins other than Pho4p regulate PHO5 
transcription (Fig. 11).  This is also evidence of coordination between the PHO regulation 
and phospholipid biosynthetic pathways.  The fact that INO4 and INO2 were required for 
PHO5 expression is consistent with two reports.  A genome-wide screen of the viable 
yeast deletion set identified ino4Δ as defective in expression of PHO5 [225].  While 
ino2Δ was not identified in this screen, it has been reported (as an unpublished result) to 
affect expression of PHO5 [277]. 
4.1 A Model for Inositol Regulation of PHO5  
A model for activation of PHO5 is that Pho2p binds to UASp1 and recruits the 
NuA4 HAT complex under repressing conditions (high Pi).  NuA4 acetylation of H4 and 
H2A on the PHO5 promoter is a pre-requisite for efficient Pho4p binding to the UASp2 
site under inducing conditions (low Pi) [213] and displacement of nucleosomes over the 
UASp2 and UASp3 regions [215].  Our results build on this model and suggest that 
inositol regulation is dependent on Pho4p-dependent displacement of the nucleosome 
occluding the UASp3 site (Fig. 18).  Consistent with previous knowledge, our data 
showed that Pho4p is responsible for phosphate-mediated regulation through the UASp1 
(-356) and UASp2 (-247) sites (Fig. 14C).  Ino2p/Ino4p play an important role in 
inositol-mediated regulation via the UASp3 (-194) element (Fig. 14C).  Our epistasis 
results suggest that inositol regulation is exerted through the UASp3 element (Fig. 14) 
and the ChIP studies show that UASp3 likely binds Ino2p/Ino4p.  ChIP assays clearly 
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showed 13myc-Pho4p and Ino2p-TAP, and Ino4p-TAP enrichment in the PHO5 promoter 
regions containing the UASp1, UASp2, and UASp3 elements (Fig. 15).  The ChIP 
pattern for Pho4p showed that it binds in a phosphate-dependent manner further upstream 
than Ino2p/Ino4p (Fig. 15B).  Ino2p/Ino4p binding was further enhanced in I-C- media 
(Fig. 15D and E) which is consistent with the fact that Ino2p is up-regulated 12-fold 
under this growth condition [240].  It is worth noting that published ChIP-chip studies on 
transcription factor binding sites in the yeast genome do not identify Ino2p and Ino4p 
binding to the PHO5 promoter [278, 279].  This difference could be due to a trivial 
reason such as growth condition or could be due to differences in the sensitivity of the 
ChIP assays.  Several lines of evidence suggest that inositol regulation of PHO5 
expression is dependent on phosphate regulation and mechanistically distinct from 
phosphate regulation.  First, deleting PHO4 eliminated both phosphate and inositol 
regulation, while deleting INO2 or INO4 only eliminated inositol regulation (Fig. 11).  
Second, Pho4p binding was not subject to inositol regulation while Ino2p and Ino4p 
binding was subject to phosphate regulation (Fig. 15).  Third, deleting PHO4, or its two 
main binding sites, eliminated binding of Ino2p:Ino4p (Fig. 16). Lastly, mutations in the 
phosphate regulatory cascade (pho80Δ and pho81Δ) did not affect inositol-mediated 
regulation of PHO5-lacZ (data not shown).   
Because Ino2p:Ino4p binding is dependent on Pho4p binding, it was not possible to 
use ChIP to define the exact binding site for Ino2p:Ino4p. However, inositol-mediated 
regulation of PHO5 through the UASp3 element (-194 E-box) is consistent with results 
from two studies that identified the sequence requirements for Ino2p/Ino4p binding and 
inositol regulation of heterologous reporters (UASINO element and/or inositol/choline 
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responsive element (ICRE)) [234, 280].  The optimal UASINO element and ICRE 
sequences (TTCACATG) are comparable to the UASp3 element, CGCACATG [234, 
280].  Moreover, the UASINO study showed that while changing the first two bases 
immediately flanking the 5’ end of the core bHLH site to a CG affects overall activity of 
the element, they did not affect inositol regulation of a reporter gene [280]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
72 
Fig. 18.  Model for regulation of PHO5 transcription by Ino2p:Ino4p and Pho4p.  Yellow 
circles refer to positioned nucleosomes and T denotes TATA box.  Boxes refer to UASp1 
and UASp2 (solid) and UASp3 (shaded).  Thickness of arrow next to TATA box refers to 
relative transcription rate.  Green circles refer to transcription activators and the darker 
Ino2p:Ino4p green circle under I- conditions refers to the fact that there is 12-fold more 
Ino2p under this growth condition. Refer to discussion for complete description of model. 
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4.2 Significance of Inositol-Mediated Regulation of PHO5  
4.2.1 An Evolutionary Perspective 
An important issue to address is the significance of the inositol-mediated regulation 
of PHO5.  One way to address this is to ascertain the conservation of the UASp3 element 
among the Saccharomyces genus.  Thus, we compared 1Kb of sequences upstream of 
PHO5 orthologs from different species of Saccharomyces using the SGD Fungal 
Sequence Alignment tool (http://www.yeastgenome.org/cgi-bin/FUNGI/showAlign).  
Predictably, the UASp1 (-356 E-box) and UASp2 (-247) elements were conserved in all 
species (Fig. 19).  The UASp3 (-194 E-box) element was conserved in all species except 
S. bayanus, which contained a single nucleotide variant (Fig. 19).  In contrast, the other 
three potential E-boxes (-145, -343, and -668) showed multiple variations in multiple 
species.  These observations suggest that the UASp1, UASp2, and UASp3 play essential 
roles in regulation of PHO5 expression.  The fact that the UASp3 is not conserved in S. 
bayanus implies that inositol-mediated regulation of PHO5 evolved later than phosphate 
regulation.  This is consistent with the fact that the PHO5 response to inositol/choline is 
modest compared with the response to phosphate and not identified in expression 
profiling studies [273, 281].  However, while the inositol regulation of PHO5 is moderate, 
it is more significant than that of several previously characterized inositol-regulated 
genes involved in fatty acid synthesis and the Kennedy pathway for phospholipid 
synthesis (FAS1, FAS2, ACC1, CPT1) [282-284].  
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Fig. 19.  Conservation of 3 functional UAS elements in the PHO5 promoter among the 
Saccharomyces genera.  The relevant sequences of the PHO5 promoters from 6 
Saccharomyces species were compared using the Fungal Alignment link in 
http://www.yeastgenome.org/.  The Saccharomyces species are ordered in terms of 
relatedness from top to bottom.  The sequences of the relevant UAS elements in the 
PHO5 promoters are shown.  The identity of the variant nucleotide is underlined.   
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4.2.2 Physiological Rationale for Cross Regulation between Phospholipid 
Synthesis and Phosphate Utilization 
One obviously important question for this study is: why is phosphate utilization and 
phospholipid biosynthesis in budding yeast coordinated?  A possible answer may lie in 
the facts that certain phospholipids can serve as a phosphate source [285] and that 
phospholipid biosynthesis requires phosphate [277].  For example, 
glycerophosphodiesters such as glycerophosphoinositol (GroPIns) and 
glycerophosphocholine (GroPCho) can be produced from phosphatidylinositol (PI) or 
phosphatidylcholine (PC) through deacylation by phospholipase B [286].  Their 
hydrolytic products provide important nutrients such as inositol, choline and phosphate 
[286].  Extracellular GroPIns can be the sole supply of inositol or phosphate for 
producing PI when either component is limiting in the medium [285, 287].  A permease 
encoded by GIT1 imports extracellular glycerophosphodiesters across the plasma 
membrane for this purpose [287, 288].  Interestingly, studies show that Pho4p, Pho2p, 
Ino2p and Ino4p regulate GIT1 expression and Git1p transport activity in response to 
phosphate limitation and/or inositol limitation [285]. The magnitude of phosphate 
regulation is far greater than that elicited by inositol starvation with respect to induction 
of GIT1 expression levels and Git1p transport activity [285].  
In addition to phospholipases, phosphatases also contribute to the dephosphorylation 
of different substrates and release free phosphates.  For example, Ymr1p, Fig4p, Inp51p 
and Inp54p are phosphatases specific for one polyphosphoinositide while Sac1p, Inp52p 
and Inp53p use many polyphosphoinositides as a substrate [289].  The dephosphorylation 
of phosphatidic acid yielding diacylglycerol and phosphate can be catalyzed by specific 
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phosphatases Pah1p and App1p or non-specific enzymes Dpp1p and Lpp1p [290].   
 
4.3 Additional Evidence for Phosphate/Inositol Cross Regulation  
There are also several additional examples of cross regulation between the phosphate 
utilization and phospholipid synthesis pathways.  For example, regulation of 
phospholipid synthesis occurs via phosphorylation of transcription factors and enzymes at 
a serine or threonine residue by protein kinases A and C, casein kinase II and a cyclin-
dependent kinase [291].  The Opi1p transcriptional repressor, the Cho1p 
phosphatidylserine synthase, the Pah1p phosphatidic acid phosphatase, the Cki1p choline 
kinase, and the URA7/URA8-encoded CTP synthases are all regulated by 
phosphorylation [291].  
Other evidence of the coordination between phosphate utilization and phospholipid 
synthesis lies in studies of inositol pyrophosphates.  Inositol heptakisphosphate (IP7), a 
product of PI metabolism [292], is a signaling molecule of the PHO regulon [229, 230].  
IP7 was found to specifically bind to and inhibit the Pho80p-Pho81p-Pho85p complex 
[230].   
Other experiments show the importance of inositol pyrophosphates in phosphate and 
inositol metabolism.  A genome-wide screen of the budding yeast deletion collection 
identified that three genes PLC1, ARG82, and KCS1, which are involved in the synthesis 
of inositol polyphosphate, function upstream of Pho81p and negatively regulate the PHO 
pathway [293].  Consistent with this study, the analysis of four yeast mutants (plc1Δ, 
arg82Δ, ipk1Δ, kcs1Δ) which are unable to synthesize inositol pyrophosphates, show that 
the absence of inositol pyrophosphates yields a dramatic decrease in the cellular level of 
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polyphosphates (polyPi) [294].  The kcs1Δ mutant strain displays reduced phosphate 
uptake indicating that inositol pyrophosphates also regulate the cellular entry of Pi [295].  
A novel mechanism underlying the regulation of KCS1 transcription in response to 
phosphate signals was identified [296].  Pho4-mediated transcription of the antisense and 
intragenic RNAs in the KCS1 locus leads to the production of truncated Kcs1p and down-
regulation of Kcs1p kinase activity [296].  In addition to participating in phosphate 
homeostasis, inositol pyrophosphates also play roles in inositol metabolism.  A study 
shows that Kcs1p protein levels control INO1 transcription by regulating the synthesis of 
inositol pyrophosphates [297].  
 
4.4 Regulation of PHO4 Expression and Pho4p Activity  
While the role of Pho4p as a transcription activator of the PHO regulon is well 
characterized, the regulation of PHO4 expression had not been intensively investigated.  
There is one study that reports that PHO4 and PHO4-lacZ are expressed at a low level 
and independent of the PHO regulatory system and phosphate in the medium [298].  This 
is in contrast to our results, where we found that expression of a PHO4-cat reporter is 
induced in high Pi media and dependent on Pho4p which is the opposite effect of Pi on 
Pho4p target gene expression (Fig. 17).  The conflict may be explained by the fact that 
Cat assays have a lower limit of sensitivity than northern blot hybridization and lacZ 
assays [299].  However, we are still left with explaining how Pho4p functions as an 
activator under normally repressive conditions (high Pi)?  There is one genome-wide 
study that may shed light on understanding of Pho4p regulation [296].  This report 
suggested that Pho4p is present in the nucleus even under the high-Pi condition and can 
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function independent of phosphate conditions to activate or repress target gene 
transcription [296].  The authors show that this happens through phosphorylation of 
Pho4p at Ser242 and Ser243 by a kinase other than Pho85 preventing it from 
phosphorylation by Pho85 (at Ser 100,114, 128, 152, and 223), thereby decreasing the 
affinity of Pho4 for the Msn5 nuclear exportin [296, 300].  There is one example of 
Pho4p as a repressor in that it can negatively regulate the expression of SNZ1, a 
stationary phase-specific gene, by evoking the alteration of chromatin structure [301].  
Regardless of the explanation, our results raise several questions.  Why does low Pi 
medium down-regulate PHO4 transcription (Fig. 17) but induce PHO5 expression (Fig. 
11A)?  There is a recent report showing that ribosomal protein Rpl12p affects the 
transcription of PHO4 and downstream PHO genes in opposite ways although the 
mechanism for this is not clear [302].  This could be due to indirect effects or post-
transcriptional regulation of PHO4 expression.  There is a recent report that Pho92p 
regulates Pho4 expression via binding to the 3’-UTR of PHO4 mRNA and reducing its 
stability under high-Pi conditions [303].  Another question is: do Ino2p and Ino4p play a 
role in phosphate-mediated regulation of PHO4 transcription (Fig. 17) and where are the 
PHO4 promoter cis-elements for these bHLH regulators?  We assayed mutants in all four 
potential E-boxes in the PHO4 promoter (-108, -207, -335, and -558) and found that they 
did not have an effect on a PHO4-cat reporter gene expression (data not shown).  Thus, 
regulation of PHO4 by Ino2p, Ino4p and Pho4p may be indirect and the consequence of 
this regulation remains to be determined.  
 
4.5 Final Thoughts  
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A recent genome-wide study of Pho4p binding by the O’Shea lab illuminated how 
different factors affect the binding and function of a transcription regulator [304].  In this 
study they found Pho4p is bound to only 14% of its consensus binding sites, and only a 
quarter of those binding events result in activation of gene transcription [304].  They 
concluded the Pho4p binding and function are determined by a combination of chromatin 
restriction, competitive binding from the factor Cbfp1 that recognizes the same motif as 
Pho4p, and cooperativity with Pho2p [304].  They described two roles for Pho4p-Cbf1p 
competition: in high-Pi conditions, Cbf1p prevents activation of the PHO target genes 
induced by a low level of nuclear Pho4p, ensuring that phosphate-responsive genes are 
turned off when Pi is available.  However, in low-Pi conditions, Cbf1p prevents Pho4p 
from inappropriately activating genes containing a ‘CACGTG’ motif that are not part of 
the phosphate regulon [304].  Thus, microarray data show that in high-Pi conditions 
deletion of CBF1 leads to Pho4p binding to PHO5 therefore turning on its transcription, 
but deletion of RTG3 or TYE7 (both protein products bind to ‘CACGTG’ motif) do not 
elevate PHO5 expression [304].  They also performed CHIP-seq experiments that 
showed Pho4p and Cbf1p binding to 13 target genes that did not include PHO5 [304].  
This study shows how Cbf1p is involved in the cross regulation of the PHO5 gene by 
Pho4p but do not clarify how Ino2p/Ino4p function in the context of Cbf1p effects. 
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